FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311589178> ?p ?o ?g. }

• W4311589178 endingPage "e0256788" @default.
• W4311589178 startingPage "e0256788" @default.
• W4311589178 abstract "Oncogenic kinase inhibitors show short-lived responses in the clinic due to high rate of acquired resistance. We previously showed that pharmacologically exploiting oncogene-induced proteotoxic stress can be a viable alternative to oncogene-targeted therapy. Here, we performed extensive analyses of the transcriptomic, metabolomic and proteostatic perturbations during the course of treatment of Her2+ breast cancer cells with a Her2 inhibitor covering the drug response, resistance, relapse and drug withdrawal phases. We found that acute Her2 inhibition, in addition to blocking mitogenic signaling, leads to significant decline in the glucose uptake, and shutdown of glycolysis and of global protein synthesis. During prolonged therapy, compensatory overexpression of Her3 allows for the reactivation of mitogenic signaling pathways, but fails to re-engage the glucose uptake and glycolysis, resulting in proteotoxic ER stress, which maintains the protein synthesis block and growth inhibition. Her3-mediated cell proliferation under ER stress during prolonged Her2 inhibition is enabled due to the overexpression of the eIF2 phosphatase GADD34, which uncouples protein synthesis block from the ER stress response to allow for active cell growth. We show that this imbalance in the mitogenic and proteostatic signaling created during the acquired resistance to anti-Her2 therapy imposes a specific vulnerability to the inhibition of the endoplasmic reticulum quality control machinery. The latter is more pronounced in the drug withdrawal phase, where the de-inhibition of Her2 creates an acute surge in the downstream signaling pathways and exacerbates the proteostatic imbalance. Therefore, the acquired resistance mechanisms to oncogenic kinase inhibitors may create secondary vulnerabilities that could be exploited in the clinic." @default.
• W4311589178 created "2022-12-27" @default.
• W4311589178 creator A5011555706 @default.
• W4311589178 creator A5026834716 @default.
• W4311589178 creator A5039222777 @default.
• W4311589178 creator A5053865107 @default.
• W4311589178 creator A5061302509 @default.
• W4311589178 date "2022-12-08" @default.
• W4311589178 modified "2023-09-26" @default.
• W4311589178 title "Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers" @default.
• W4311589178 cites W1520023565 @default.
• W4311589178 cites W1977594275 @default.
• W4311589178 cites W1991999080 @default.
• W4311589178 cites W1997579117 @default.
• W4311589178 cites W2014445008 @default.
• W4311589178 cites W2015368735 @default.
• W4311589178 cites W2016061706 @default.
• W4311589178 cites W2017693082 @default.
• W4311589178 cites W2019490712 @default.
• W4311589178 cites W2023300506 @default.
• W4311589178 cites W2028866472 @default.
• W4311589178 cites W2057742567 @default.
• W4311589178 cites W2062473455 @default.
• W4311589178 cites W2077813812 @default.
• W4311589178 cites W2080378383 @default.
• W4311589178 cites W2093575933 @default.
• W4311589178 cites W2093985232 @default.
• W4311589178 cites W2100472948 @default.
• W4311589178 cites W2103808574 @default.
• W4311589178 cites W2120736516 @default.
• W4311589178 cites W2122972184 @default.
• W4311589178 cites W2123206362 @default.
• W4311589178 cites W2126315551 @default.
• W4311589178 cites W2142577642 @default.
• W4311589178 cites W2142786915 @default.
• W4311589178 cites W2143044700 @default.
• W4311589178 cites W2153080167 @default.
• W4311589178 cites W2156739666 @default.
• W4311589178 cites W2161696113 @default.
• W4311589178 cites W2162475911 @default.
• W4311589178 cites W2162901058 @default.
• W4311589178 cites W2192080449 @default.
• W4311589178 cites W2516958665 @default.
• W4311589178 cites W2527582579 @default.
• W4311589178 cites W2528939866 @default.
• W4311589178 cites W2562573190 @default.
• W4311589178 cites W2617425164 @default.
• W4311589178 cites W2800107604 @default.
• W4311589178 cites W2800602004 @default.
• W4311589178 cites W2904833052 @default.
• W4311589178 cites W2943984860 @default.
• W4311589178 cites W2969277601 @default.
• W4311589178 cites W2969509842 @default.
• W4311589178 cites W2998103954 @default.
• W4311589178 cites W3016823151 @default.
• W4311589178 cites W3030794675 @default.
• W4311589178 cites W3036606715 @default.
• W4311589178 cites W4230568286 @default.
• W4311589178 doi "https://doi.org/10.1371/journal.pone.0256788" @default.
• W4311589178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36480552" @default.
• W4311589178 hasPublicationYear "2022" @default.
• W4311589178 type Work @default.
• W4311589178 citedByCount "1" @default.
• W4311589178 countsByYear W43115891782023 @default.
• W4311589178 crossrefType "journal-article" @default.
• W4311589178 hasAuthorship W4311589178A5011555706 @default.
• W4311589178 hasAuthorship W4311589178A5026834716 @default.
• W4311589178 hasAuthorship W4311589178A5039222777 @default.
• W4311589178 hasAuthorship W4311589178A5053865107 @default.
• W4311589178 hasAuthorship W4311589178A5061302509 @default.
• W4311589178 hasBestOaLocation W43115891781 @default.
• W4311589178 hasConcept C104317684 @default.
• W4311589178 hasConcept C114851261 @default.
• W4311589178 hasConcept C121608353 @default.
• W4311589178 hasConcept C134935766 @default.
• W4311589178 hasConcept C139447449 @default.
• W4311589178 hasConcept C1491633281 @default.
• W4311589178 hasConcept C158617107 @default.
• W4311589178 hasConcept C184235292 @default.
• W4311589178 hasConcept C2776131300 @default.
• W4311589178 hasConcept C2777658100 @default.
• W4311589178 hasConcept C2778502085 @default.
• W4311589178 hasConcept C2781018059 @default.
• W4311589178 hasConcept C29537977 @default.
• W4311589178 hasConcept C2994587330 @default.
• W4311589178 hasConcept C502942594 @default.
• W4311589178 hasConcept C54355233 @default.
• W4311589178 hasConcept C55493867 @default.
• W4311589178 hasConcept C62112901 @default.
• W4311589178 hasConcept C62478195 @default.
• W4311589178 hasConcept C86803240 @default.
• W4311589178 hasConcept C95444343 @default.
• W4311589178 hasConcept C96232424 @default.
• W4311589178 hasConceptScore W4311589178C104317684 @default.
• W4311589178 hasConceptScore W4311589178C114851261 @default.
• W4311589178 hasConceptScore W4311589178C121608353 @default.
• W4311589178 hasConceptScore W4311589178C134935766 @default.
• W4311589178 hasConceptScore W4311589178C139447449 @default.

• next